DENTSPLY SIRONA market cap XRAY
Share price times shares outstanding: what the whole company sells for, since 2009.
- Today, Nov 2, 2026
- $2B
- Highest close in our data
- $15.6B
- Jan 2018
DENTSPLY SIRONA is worth $2B at the close on Nov 2, 2026, at $9.90 a share.
That is down 12% over the last year and down 84% over five years.
Its highest close in our data was $15.6B in Jan 2018.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $2B | $1.7B | $2.9B | −14% |
| 2025 | $2.3B | $2.1B | $3.9B | −39% |
| 2024 | $3.8B | $3.6B | $7.7B | −50% |
| 2023 | $7.5B | $6B | $9B | +10% |
| 2022 | $6.8B | $5.9B | $12.8B | −44% |
| 2021 | $12.2B | $10.9B | $14.9B | +7% |
| 2020 | $11.4B | $7.3B | $13.3B | −9% |
| 2019 | $12.6B | $8.7B | $13.8B | +53% |
| 2018 | $8.3B | $7.6B | $15.6B | −45% |
| 2017 | $15.1B | $12.1B | $15.5B | +13% |
| 2016 | $13.3B | $7.7B | $15B | +57% |
| 2015 | $8.5B | $7B | $8.8B | +12% |
| 2014 | $7.6B | $6.3B | $7.9B | +11% |
| 2013 | $6.9B | $5.7B | $6.9B | +25% |
| 2012 | $5.5B | $5B | $5.9B | +12% |
| 2011 | $5B | $4.3B | $5.6B | +2% |
| 2010 | $4.9B | $4.1B | $5.4B | −7% |
| 2009 | $5.2B | $4.9B | $5.3B | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest DENTSPLY SIRONA's size, closest first, today.
| Company | Market cap |
|---|---|
| XRAYDENTSPLY SIRONA | $2B |
| INSPInspire Medical Systems | $1.9B |
| LMATLemaitre Vascular | $1.9B |
| UFPTUFP Technologies | $2.2B |
| EYENational Vision | $1.4B |
| CDRECadre | $1.3B |
| WRBYWarby Parker | $2.9B |
| ATRCAtriCure | $3B |
| STAAStaar Surgical | $1.3B |
| BVSBioventus | $1.1B |
| IARTIntegra Lifesciences | $1.1B |
| Peer median | $1.6B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on DENTSPLY SIRONA
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.